Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in INR
The 2 analysts offering 12 month price targets for Caplin Point Laboratories Ltd have a median target of 1,807.50, with a high estimate of 2,080.00 and a low estimate of 1,535.00. The median estimate represents a -6.59% decrease from the last price of 1,935.00.
High | 7.5% | 2,080.00 |
Med | -6.6% | 1,807.50 |
Low | -20.7% | 1,535.00 |
Dividends
Div growth (TTM) | 11.11% |
---|
More ▼
Earnings history & estimates in INR
Average growth rate | +20.83% |
More ▼
Revenue history & estimates in INR
Average growth rate | +3.82% |
Average growth rate | +18.40% |
More ▼